Portfolio

Accumetrics, Inc., San Diego, CA

Medical diagnostics company commercializing the VerifyNow®
System for the assessment of platelet function in patients taking
antiplatelet therapies.
PRIVATE

CGI Pharmaceuticals, Inc., Branford, CT

Acquired by Gilead Sciences, Inc. (GILD)
Biopharmaceutical company developing novel therapeutics targeting
protein kinases for cancer and autoimmune/inflammatory diseases.
ACQUIRED

Cabrellis Pharmaceuticals Corporation, San Diego, CA

Acquired by Pharmion Corporation (PHRM)
Specialty pharmaceutical company developing therapies
for the treatment of cancer.
ACQUIRED

Calypso Medical Technologies, Inc., Seattle, WA

Acquired by Varian Medical Systems, Inc. (VAR)
Medical device company commercializing a proprietary
localization system to improve accuracy and management
of external beam radiation therapy.
ACQUIRED

Cameron Health, Inc., San Clemente, CA

Acquired by Boston Scientific Corporation (BSX)
Medical device company developing a next-generation
implantable defibrillator that is easier to implant and
does not require leads that attach to the heart.
ACQUIRED

Centerre Healthcare Corporation, Brentwood, TN

Healthcare services company developing and operating
inpatient rehabilitation facilities in partnership with
leading acute care hospitals.
PRIVATE

Conforma Therapeutics Corporation, San Diego, CA

Acquired by Biogen Idec (BIIB)
Biotechnology company developing drugs that target a novel
pathway, HSP90 inhibition, for the treatment of cancer.
ACQUIRED

CyDex Pharmaceuticals, Inc., Overland, KS

Acquired by Ligand Pharmaceuticals Incorporated (LGND)
Specialty pharmaceutical company commercializing a
proprietary technology that improves drug solubility.
ACQUIRED

Excaliard Pharmaceuticals, Inc., Carlsbad, CA

Acquired by Pfizer, Inc. (PFE)
Biopharmaceutical company focused on developing drugs
for the local treatment of fibrosis, including skin scarring.
ACQUIRED

IDev Technologies, Inc., Houston, TX

Medical device company commercializing a novel stent
for the treatment of peripheral vascular disease.
PRIVATE

Kaperio, Inc., St. Louis, MO

Seed-stage biopharmaceutical company focused
on cardiovascular disease.
PRIVATE

Kereos, Inc., St. Louis, MO

Biotechnology company developing site-targeted drugs
and molecular imaging agents for cancer
and cardiovascular disease.
PRIVATE

Lumena Pharmaceuticals, Inc., Research Triangle Park, NC

Biopharmaceutical company developing treatments for
metabolic diseases through non-systemically absorbed
compounds having targets within the lumen of the GI tract.
PRIVATE

Luminous Medical, Inc., Carlsbad, CA

Medical device company developing an innovative automated
glucose measurement system to facilitate tight glycemic
control in hospital settings.
PRIVATE

Lutonix, Inc., Minneapolis, MN

Acquired by C.R. Bard, Inc. (BCR)
Medical device company developing drug-coated balloon catheters
for the treatment of vascular disease.
ACQUIRED

MacroGenics, Inc., Rockville, MD

Leading antibody therapeutics company with a focus on
autoimmune diseases and cancer.
PRIVATE

Mpex Pharmaceuticals, San Diego, CA

Acquired by Aptalis
Biopharmaceutical company developing an inhaled antibiotic
for the treatment of cystic fibrosis and chronic obstructive
pulmonary disease, and new therapies to combat the growing
issue of antibiotic resistance.
ACQUIRED

Neuros Medical, Willoughby, OH

Medical device company developing neurostimulation therapies
for patients with chronic pain including neuroma/residual limb
pain with future applications in chronic post-surgical pain.
PRIVATE

Otonomy, Inc., San Diego, CA

Biopharmaceutical company developing novel drug therapies for
disorders of the inner and middle ear.
PRIVATE

Salient Surgical Technologies, Inc., Portsmouth, NH

Acquired by Medtronic, Inc. (MDT)
(Formerly TissueLink) Medical device company commercializing
innovative radio-frequency electrosurgical instruments for orthopedic,
spine, and general surgery.
ACQUIRED

Securus Medical Group, Inc., Cleveland, OH

Medical device company developing clinical tools to monitor
core body temperature within body cavities in order to avoid
thermal injury to the tissue due to energy from various sources.
PRIVATE

Tryton Medical, Inc., Durham, NC

Medical device company commercializing novel stent systems
for the treatment of bifurcation lesions in coronary arteries.
PRIVATE

Velocimed, LLC, Minneapolis, MN

Acquired by St. Jude Medical, Inc. (STJ)
Leading medical device company developing endovascular
and cardiology-related technologies.
ACQUIRED

Xcyte Therapies, Inc., Seattle, WA

IPO, then acquired by Cyclacel Pharmaceuticals (CYCC)
Biotechnology company developing novel cell-based
immunotherapeutic treatments for cancer and infectious disease.
IPO

Xoft, Inc., Fremont, CA

Acquired by iCAD, Inc. (ICAD)
Medical device company commercializing electronic, miniaturized
x-ray technology for use in radiation oncology.
ACQUIRED